---
title: "Moderna declines 3% in regular trading after downgrade, dilution concerns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298047460.md"
description: "Moderna (MRNA) declined 3% after a downgrade to Sell and $2.6B notes offering sparked dilution fears."
datetime: "2026-09-04T13:46:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298047460.md)
  - [en](https://longbridge.com/en/news/298047460.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298047460.md)
generator: "portal-rs"
---

# Moderna declines 3% in regular trading after downgrade, dilution concerns

Moderna(MRNA.US) 09/04/2026 盘中急跌，当日跌 2.69%，现报**144.87 美元**。

近日 Rothschild Redburn 因估值担忧将 Moderna 评级从持有下调至卖出，尽管基于 mRNA 肿瘤疫苗 V940 的 III 期临床试验积极结果将目标价从**40 美元**上调至**81 美元**，但分析师认为当前投资者对广泛采用的预期缺乏数据支撑。公司此前宣布发行**26 亿美元**可转换优先票据用于肿瘤管线投资，引发市场摊薄担忧。此外，首席法律官 Shannon Thyme Klinger 于 9 月初通过 10b5-1 计划出售约**48.5 万美元**股票，进一步施压股价。

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)

## Related News & Research

- [Moderna (NASDAQ:MRNA) Insider Sells $485,766.45 in Stock](https://longbridge.com/en/news/297959605.md)
- [Moderna Chief Legal Officer Shannon Thyme Klinger disposes of USD 485,271.45 in common shares](https://longbridge.com/en/news/297958452.md)
- [Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It](https://longbridge.com/en/news/298134130.md)
- [Moderna Raises $3.0 Billion via 2032 Zero-Coupon Converts; Adds Capped Calls to Limit Dilution](https://longbridge.com/en/news/297697426.md)
- [15 Stocks to Watch With Short Squeeze Potential](https://longbridge.com/en/news/297819476.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**